BIIB091 |
| Catalog No.GC63846 |
BIIB091 is a highly selective, reversible and orally active BTK inhibitor for treating autoimmune diseases.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2247614-80-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
BIIB091 is a highly selective, reversible BTK inhibitor for treating autoimmune diseases.
[1]. Hopkins BT, et al. Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis. J Med Chem. 2021 Nov 4.
Review for BIIB091
Average Rating: 5 (Based on Reviews and 2 reference(s) in Google Scholar.)
Review for BIIB091
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *